The effects of magnesium, an endogenous in hibitor of calcium entry into neurons, upon ischemic brain damage were investigated using a well-character ized model of focal cerebral ischemia in rats. Infarct vol umes were determined by 2,3,5-triphenyltetrazolium chloride transcardiac perfusion 48 h after middle cerebral artery (MCA) occlusion. The area of ischemic damage was quantified by image analysis in coronal sections taken every 0.5 mm. MgCI2 (l mmol/kg) was injected in-Abbreviations used: BBB, blood-brain barrier; MCA, middle cerebral artery; NMDA, N-methyl-o-aspartate; TTC, 2,3,5triphenyltetrazolium chloride. 1025 traperitoneally just after MCA occlusion and again 1 h later. Posttreatment with MgCl2 (16 control and 16 treated rats) significantly reduced the cortical infarct volume. Compensation for the hyperglycemic effect of MgCl2 with insulin (17 rats) further reduced the infarct volume in the neocortex. No systemic effects of either treatment could account for the observed neuroprotection. Key Words: Fo cal cerebral ischemia-Glucose-Infarct size Magnesium-Neuroprotection.
Magnesium plays an essential role in cellular physiology. It is involved in the activation of � 300 enzymes, including those catalyzing energy producing and energy-consuming reactions (Ebel and Gunther, 1980) . In the extracellular space, mag nesium competes with calcium to reduce calcium entry into cells (Altura and Altura, 1981) , blocks both voltage-sensitive and N-methyl-D-aspartate (NMDA)-activated channels (Iseri and French, 1984; Nowak et aI. , 1984) , is implicated in the reg ulation of cerebral vascular tone (Seelig et aI. , 1983) , and inhibits the release of excitatory amino acids (Rothman, 1984) . These properties make mag nesium an excellent candidate for preventing brain damage.
There is evidence that the neuronal death that follows cerebral ischemia may be due to a massive release of excitatory amino acids, particularly glu tamate (Rothman and Olney, 1986) . Most studies suggest that a calcium influx into neurons is a cru cial step of the deleterious cascade triggered by ischemia (Schanne et aI. , 1979; Siesj6 and Bengts son, 1989) . Several studies have demonstrated that magnesium can protect against anoxic damage in vitro (Ames and Nesbett, 1983; Rothman, 1983; Kass et aI. , 1988) and against applied glutamate (Gibson and Reif-Lehrer, 1985) . Treatment with magnesium has also been shown to limit damage and improve outcome after global cerebral ischemia (Tsuda et aI. , 1989) , brain trauma (Vink et aI. , 1988; McIntosh et aI. , 1989) , and spinal cord ischemia (Vacanti and Ames, 1984; Robertson et aI. , 1986) .
We have therefore investigated whether treat ment with MgCl 2 can reduce infarct volume in rats following focal cerebral ischemia. Intracranial oc clusion of the middle cerebral artery (MCA) in rats has been chosen because it results in highly repro ducible lesions. There is good evidence that this model is most pertinent in terms of pharmacological therapy of stroke (MacKenzie et aI. , 1986) . The ef fects of administering a combination of MgCl 2 and insulin were also investigated so as to minimize any influence of magnesium-induced hyperglycemia.
Induction of focal ischemia
The rats were anesthetized with halothane (1.5%) in oxygen. Rectal temperature was measured and main tained within the normal physiological range during sur gery. Left MCA occlusion was performed by a subtem poral approach, essentially as described by Tamura et al. (1981) . The rat was placed on its right side, and a vertical incision was made between the left orbit and the external auditory canal. The temporal muscle was divided midway vertically and reflected forward and downward with a retractor. The left eye and the parotid gland were left in place, but the posterior half of the zygomatic bone was removed. The inferotemporal fossa was exposed under a surgical microscope, and a small craniotomy was made using a dental drill. The dura was incised and reflected. Bipolar microcoagulation forceps were used to occlude the MCA from the point where it crosses the inferior cerebral vein to the superior aspect of the olfactory tract. The lenticulostriate arteries were also coagulated. The skin was then sutured, anesthesia was turned off, and the animals were returned to their cages. All experimental procedures were carried out in strict accordance with Na tional Institutes of Health guidelines.
Experimental paradigms
The rats were randomly divided into three groups: con trol group (n = 16), magnesium-treated group (n = 16), and magnesium + insulin-treated group (n = 17). The rats in the control group were given isotonic saline (2 ml/kg i.p.) once after occlusion and a second time 60 min later, i.e. �50 min after completion of anesthesia. The rats in the magnesium-treated group were given two in traperitoneal injections of magnesium chloride (MgCI2, 1 mmoUkg), one immediately after occlusion and the other 60 min later. The rats in the magnesium + insulin-treated group were given an intraperitoneal injection of insulin (1 u/kg) together with the first MgCl2 injection (1 mmol/kg) and the same dose of MgCl2 alone 60 min later. The doses and injection timing of MgCl2 and insulin were deter mined on the basis of pilot experiments.
In addition, 12 rats were used to accurately evaluate the combined effects of MCA occlusion and either treat ment on systemic variables.
MgCl2 (magnesium chloride solution; Sigma Diagnos tics, U.S.A.) was dissolved in saline and a volume of 2 mllkg was injected twice. A fast, short-acting insulin (Actrapid 5 HM; Novo, France) was used.
Measurement of infarct volume
Infarcts were delineated by 2,3,5-triphenyltetrazolium chloride (TTC) staining (Liszczak et aI., 1984; Bederson et aI., 1986) . The rats were reanesthetized with halothane (2.5%) in oxygen 48 h after the induction of focal cerebral ischemia and heparin (200 IU) was injected into the sa phenous vein. The rats were then perfused with 2% TTC in distilled water for 10 min via a catheter placed in the ascending aorta via the apex of the left ventricle. The brain was left in place for 45 min to ensure reduction of the TTC to a colored formazan by viable dehydrogenases. The brain was then carefully removed, cooled in isopen tane (-50°C), and sectioned in a cryomicrotome (-20°C). Black and white photographs were taken every 0.5 mm covering the whole cerebral infarct level. The areas of infarcted brain in the cortex and striatum were determined from these photographs with a computer-J Cereb Blood Flow Metab. Vol. 11, No.6, 1991 based image analyzer (Histopericolor, MS2I). The infarct volume was calculated from the area of necrotic tissue at each brain level and the distance between succeeding slices (0.5 mm).
Measurement of systemic variables
A polyethylene catheter filled with heparinized saline was chronically inserted into a femoral artery 24 h before occlusion. The catheter was canalized subcutaneously to exit at the neck. Before MCA occlusion and at various times after occlusion, the catheter was connected to a pressure transducer (Statham P 23 Db) for monitoring arterial blood pressure on a polygraph (Gould). Arterial oxygen and carbon dioxide tensions, arterial pH, glucose content, and rectal temperature were also measured be fore MCA occlusion and 1.5, 4, 24, and 48 h after occlu sion.
Statistical analysis
Striatal infarction analysis was performed after the rats had been sorted into separate subgroups: those that ex hibited striatal infarction and those that did not.
Statistical analysis was performed using analysis of variance followed by Tukey's test to assess the effects of treatments on infarct area and volume and also to com pare the systemic variables between groups. The changes in systemic parameters with time in each group were as sessed by analysis of variance followed by Dunnett's test. A p value of <0.05 was considered significant.
Data are presented as means ± SD.
RESULTS
No postoperative deaths or seizures occurred in the control group. Two rats died in each treated group just after MCA occlusion and thus were ruled out of the study. Within 15 min after completion of surgery, all rats awoke, but the treated rats were less reactive than the control rats. At 24 and 48 h after MCA occlusion, all rats had a similar behav ior.
Assessment of systemic variables
No significant differences between the physiolog ical variables of the control and treated groups were measured, either before or at any time after MCA occlusion, except for the blood glucose content (Ta ble 1). Glycemia was significantly higher in MgCI 2treated rats than in the two other groups at 1.5 h after occlusion. Later, at 4 h after occlusion, glyce mia in the MgClrtreated group was still signifi cantly above its preocclusion level, though not sig nificantly different from the other groups. Blood glucose had returned to its basal level within 24 h after occlusion. A slight, prolonged decrease in MABP (-20%) was induced by the operative con ditions. Arterial hypotension was significant earlier (at 1.5 h after MCA occlusion) in magnesium treated rats than in other rats, but persisted in all three groups 48 h after occlusion. 
Assessment of infarct volume
The total volumes of ischemic damage were 165 ± 20 mm3 in the control group, 122 ± 30 mm3 in the MgCl 2 -treated group (significantly smaller than in the control group), and 92 ± 27 mm3 in the MgCl 2 + insulin-treated group (significantly smaller than in both the control and the MgCl 2 -treated groups). The neocortical and striatal infarct volumes in the three groups are shown in Fig. 1 control group at most coronal planes. By contrast, the areas of ischemic damage in the striatum were similar in both groups. The areas of ischemic dam age in the neocortex of the MgCl 2 + insulin-treated group were significantly smaller than those of the control group at most coronal planes. They were also significantly smaller than those of the MgCI 2treated group in the posterior part of the neocortex. The magnitude of the reductions was similar throughout the rostrocaudal axis of the neocortex. The areas of the ischemic damage in the striatum were not significantly different from those of the control group, except at the level of bregma.
DISCUSSION
The present study demonstrates that the systemic administration of MgCl 2 r.educes the cortical dam- age induced by MCA occlusion in the rat. Preven tion of the magnesium-induced hyperglycemia by insulin further enhances the neuroprotection in the neocortex. Before discussing the putative mecha nisms by which Mg 2 + may exert its beneficial effect on focal ischemia, it should be made clear that the blood-brain barrier (BBB) is permeable to this cat ion, though poorly in nonischemic areas. While, to our knowledge, there has been no direct demonstra tion that Mg 2 + crosses the BBB, indirect evidence strongly supports the fact that systemic hypermag nesemia increases the bioavailability of Mg 2 + at the neuronal level. When plasma magnesium concen tration is massively increased, as in the present study, there is a significant increase in CSF magne sium (Oppelt et al. , 1963; Thurnau et al. , 1987) . The lack of ependymal resistance to free exchange be tween the fluid in the extracellular space and the CSF (Rall, 1968; McComb, 1983) allows us to state that the parenchymal Mg 2 + concentration is in creased when a high dose of MgCl 2 is systemically given. Furthermore, the systemic injection of mag nesium induces protection at the brain level in a variety of experimental conditions: head trauma (McIntosh et al. , 1989) , spinal cord ischemia (Va canti and Ames, 1984) , and quinolinate neurotoxic ity (Wolf et al. , 1990) . Finally, in the territory of the occluded MCA, the BBB permeability increases progressively (Hatashita and Hoff, 1990) , enabling a higher level of magnesium to reach the tissue. This is supported by the fact that blood flow significantly increases within the ischemic area when magnesium is administered systemically (Chi et al. , 1990) . Thus, several types of data indicate that Mg 2 + en ters the brain. Previous studies suggest several possible mecha nisms by which magnesium produces neuroprotec tion following focal cerebral ischemia. First is the effect of magnesium on blood flow. When applied to J Cereb Blood Flow Metab. Vol. 11, No.6, 1991 pial arterioles in situ, magnesium causes a dose dependent vasodilatation that is probably due to a reduction in the influx of Ca 2 + into vascular smooth muscle cells (Seelig et al. , 1983; Altura and Altura, 1984) . Intravenously injected, magnesium induces dilatation of the basilar artery in cats after the ves sel has undergone spasm (Kapp et al. , 1970) . Fi nally, as previously mentioned, in a model of focal cerebral ischemia in rats similar to the one used in the present study, magnesium improves blood flow in the cortical territory of the occluded MCA (Chi et al. , 1990) . Consequently, it is very likely that the beneficial effects of magnesium on focal cerebral ischemia are at least partly due to vasodilatation reducing the extent of ischemia.
Magnesium may also induce neuroprotection by other mechanisms. Magnesium competes with cal cium to prevent its entry into cells and may thereby prevent cell death. NMDA provokes a large rise in Ca 2 + when it is added to cultured neurons (Mac Dermott et al. , 1986; Murphy et al. , 1987) . This rise is greatly reduced by a physiological concentration of Mg 2 + (Miller, 1988) . It has been demonstrated that Mg 2 + binds to a site within the NMDA-gated ionophore (Nowak et al. , 1984) . The blocking of the NMDA receptor-associated channel by Mg 2 + is strongly voltage dependent (Mayer et al. , 1984) . However, the persistent phase of depolarization in duced by ischemic conditions in rat hippocampal slices is selectively blocked by lowering calcium and raising magnesium as well as by NMDA antag onists. This persistent depolarization can account for the long-term synaptic failure that occurs fol lowing experimental ischemia in vitro (Rader and Lanthorn, 1989 ). In addition, Ault et al. (1980) have demonstrated that Mg 2 + selectively antagonizes NMDA-induced motoneuron depolarization and de presses the motoneuron. responses evoked by nor adrenaline, substance P, and carbachol.
This evidence that magnesium acts as an endog enous neuroprotector is supported by in vitro ex periments. Magnesium protects neurons from an oxia in cultured hippocampal neurons (Rothman, 1983) and in a rat hippocampal slice preparation (Kass et aI. , 1988) and improves the recovery of glucose metabolism in the rabbit retina subjected to ischemic conditions (Ames and Nesbett, 1983) . There is also functional evidence for Mg 2 + having an important role in neuroprotection from the fact that the rapid decrease in intracellular free Mg 2 + caused by trauma to the central nervous system is significantly correlated with the severity of injury in rats (V ink et aI. , 1988) . Furthermore, prophylactic treatment with MgS04 prevents the posttraumatic decrease in intracellular free Mg 2 + and results in a significant improvement in acute neurological out come. Similarly, posttreatment with MgCl2 pro duces a significant neurological improvement fol lowing fluid percussion brain injury in rats (McIn tosh et aI. , 1989) . MgCl2 also induces protective effects in rabbits subjected to spinal cord ischemia (Vacanti and Ames, 1984) and MgS04 protects com pletely against quinolinate neurotoxicity (Wolf et aI. , 1990) . Finally, there have been contradictory results for transient global ischemia. There appears to be no cerebral protective effect of MgCl2 after 10 min of reversible forebrain ischemia in rats (Blair et aI. , 1989) . By contrast, topical application of MgCl2 to the hippocampus preserves CAl pyramidal cells after a 20-min global ischemia whenever it is given, i. e. , before or at various postischemic intervals (Tsuda et aI. , 1989) .
In the present study, the beneficial effects of magnesium following focal cerebral ischemia may also involve its action on platelets. Magnesium has been shown to reduce platelet aggregation in vitro (Hughes and Tonks, 1965) and in vivo (Adams and Mitchell, 1979) . Magnesium could thus improve the collateral circulation in the periphery of the infarct area by decreasing platelet aggregation.
In addition, maintaining a normal blood glucose level with insulin to counteract the hyperglycemic influence of magnesium leads to enhanced neuro protection. Hyperglycemia has been shown to have deleterious effects in models of global cerebral isch emia (Siemkowicz and Hansen, 1978; Ginsberg et aI. , 1980; Pulsinelli et aI. , 1982) . In contrast to glob al ischemia, there is no clear evidence that hyper glycemia is deleterious in focal ischemia. Our re sults indirectly suggest that hyperglycemia is unfa vorable in focal ischemia. However, it is always possible that insulin itself has an effect. Insulin re ceptors have been identified in the rat brain (Havrankova et aI. , 1978) . They have also been found on platelets (Hajek et aI. , 1979) , on cerebral microvessels (Frank and Pard ridge , 198 1), and on their endothelium (Pardridge et aI. , 1985) . Rosen blum and EI-Sabban (1983) demonstrated that pre treatment with insulin delays the accumulation of aggregating platelets in damaged vessels of both normal and diabetic mice. Insulin may thus exert a beneficial effect on ischemic stroke.
In conclusion, the systemic administration of MgCl2 is neuroprotective, reducing the ischemic damage in MCA-occluded rats. The addition of in sulin enhances the Mg 2 + -induced neuroprotection by regulating glycemia and/or by direct effects on platelet aggregation. The present results provide an in vivo demonstration of the importance of magne sium for protecting against neuronal damage.
